What are the major opportunities in the Human Immunodeficiency Virus Therapeutics market? What are the strategies for the Human Immunodeficiency Virus Therapeutics market?

For detailed insights on the major opportunities and strategies in the Human Immunodeficiency Virus Therapeutics market, Read More

How does the Human Immunodeficiency Virus Therapeutics market relate to the overall economy and other similar markets?

For detailed insights on Human Immunodeficiency Virus Therapeutics's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Human Immunodeficiency Virus Therapeutics market growth? SWOT analysis of the Human Immunodeficiency Virus Therapeutics market.

For detailed insights on the key dynamics influencing the Human Immunodeficiency Virus Therapeutics market growth and SWOT analysis of the Human Immunodeficiency Virus Therapeutics industry, Read More

Human Immunodeficiency Virus Therapeutics Market Global Report 2026 Market Report Infographic Image

Published : April 2026

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Human Immunodeficiency Virus Therapeutics Market Report 2026

Name: Human Immunodeficiency Virus Therapeutics Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Drug Type (Branded Drugs, Generic Drugs), By Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), By End-user (Hospitals And Clinics, Specialty Centers) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Purchase This Report Download Sample PDF

Item added to cart!

Human Immunodeficiency Virus Therapeutics Market Overview

• Human Immunodeficiency Virus Therapeutics market size has reached to $14.9 billion in 2025

• Expected to grow to $19.4 billion in 2030 at a compound annual growth rate (CAGR) of 5.4%

• Growth Driver: Increase In Unprotected Sexual Practices Fueling The Market Due To Limited Access To Contraception And Lack Of Comprehensive Sex Education

• Market Trend: Long-Acting Injectable Prevention Breakthroughs Transforming HIV Care Accessibility And Adherence Worldwide

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Human Immunodeficiency Virus Therapeutics Market?

Human immunodeficiency virus (HIV) therapeutics refer to medications and treatment strategies designed to manage and suppress HIV infection, primarily through antiretroviral therapy (ART). These therapeutics help reduce viral load, prevent disease progression to AIDS, and improve the quality of life for individuals living with HIV.

The main drug types of human immunodeficiency virus therapeutics are branded drugs and generic drugs. Branded drugs are patented medicines developed and sold under a unique name, undergoing rigorous research and clinical trials to ensure safety and effectiveness. The drug classes include nucleoside-analog reverse transcriptase inhibitors (NRTIs), non-nucleoside reverse transcriptase inhibitors (NNRTIs), entry and fusion inhibitors, protease inhibitors (PIs), integrase inhibitors, and coreceptor antagonists. These drugs are distributed through hospital pharmacies, online pharmacies, and retail pharmacies and are used by end users such as hospitals, clinics, and specialty centers.

Human Immunodeficiency Virus Therapeutics Market Global Report 2026 Market Report bar graph

What Is The Human Immunodeficiency Virus Therapeutics Market Size and Share 2026?

The human immunodeficiency virus therapeutics market size has grown strongly in recent years. It will grow from $14.9 billion in 2025 to $15.73 billion in 2026 at a compound annual growth rate (CAGR) of 5.6%. The growth in the historic period can be attributed to global burden of hiv infections, widespread adoption of antiretroviral therapy, government-funded hiv treatment programs, increasing availability of generic hiv drugs, improved survival rates among hiv patients.

What Is The Human Immunodeficiency Virus Therapeutics Market Growth Forecast?

The human immunodeficiency virus therapeutics market size is expected to see strong growth in the next few years. It will grow to $19.4 billion in 2030 at a compound annual growth rate (CAGR) of 5.4%. The growth in the forecast period can be attributed to rising demand for long-acting hiv therapeutics, increasing focus on personalized hiv treatment regimens, expansion of access to hiv treatment in low and middle income countries, growing investments in next-generation antiretroviral drugs, increasing emphasis on lifelong hiv disease management. Major trends in the forecast period include increasing adoption of combination antiretroviral therapies, rising shift toward long-acting injectable hiv treatments, growing focus on early and sustained viral suppression, expansion of generic antiretroviral drug availability, increasing emphasis on treatment adherence and simplified regimens.

Book your 30 minutes free consultation with our research experts

Global Human Immunodeficiency Virus Therapeutics Market Segmentation

1) By Drug Type: Branded Drugs, Generic Drugs

2) By Distribution Channel: Hospital Pharmacies, Online Pharmacies, Retail Pharmacies

3) By End-user: Hospitals And Clinics, Specialty Centers

Subsegments:

1) By Branded Drugs: Biktarvy, Triumeq, Genvoya, Juluca, Dovato, Isentress, Prezista

2) By Generic Drugs: Tenofovir Disoproxil Fumarate (TDF), Lamivudine, Efavirenz, Zidovudine, Nevirapine, Abacavir, Ritonavir

What Is The Driver Of The Human Immunodeficiency Virus Therapeutics Market?

The growing prevalence of unprotected sexual practices is expected to propel the growth of the human immunodeficiency virus therapeutics market going forward. Unprotected sexual practices refer to sexual activities without barrier protection, increasing the risk of sexually transmitted infections (STIs) and unintended pregnancies. Lack of comprehensive sex education leads to limited awareness about safe practices, which increases risky behavior among youth. Human immunodeficiency virus therapeutics help reduce the risk of HIV transmission from unprotected sexual practices by suppressing viral load to undetectable levels, preventing further spread of the infection. For instance, in November 2024, according to the Centers for Disease Control and Prevention, a US-based government agency, in a 2023 survey of U.S. high school students, 32% reported having had sexual intercourse at least once, and 48% stated that they did not use a condom during their most recent sexual encounter. Therefore, the growing prevalence of unprotected sexual practices is driving the growth of the human immunodeficiency virus therapeutics industry.

Key Players In The Global Human Immunodeficiency Virus Therapeutics Market

Major companies operating in the human immunodeficiency virus therapeutics market are Gilead Sciences Inc., GlaxoSmithKline plc, Merck & Co. Inc., AbbVie Inc., Johnson & Johnson, Bristol Myers Squibb Company, Pfizer Inc., F Hoffmann La Roche Ltd., Sanofi SA, Novartis International AG, Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd., Cipla Limited, Aurobindo Pharma Limited, Hetero Labs Limited, Viatris Inc., Sun Pharmaceutical Industries Ltd., Lupin Limited, Dr Reddy's Laboratories Ltd., Mylan N.V.

Global Human Immunodeficiency Virus Therapeutics Market Trends and Insights

Major companies operating in the Human Immunodeficiency Virus Therapeutics market are focusing on developing long-acting, highly effective prevention and treatment options, expanding access through supportive reimbursement programs, and advancing innovative clinical strategies to improve adherence and reduce new HIV infections. For instance, in June 2025, Gilead Sciences, a US-based healthcare company, received FDA approval for Yeztugo (lenacapavir), the first and only twice-yearly injectable PrEP option, marking a major advancement in HIV prevention. Backed by Phase 3 PURPOSE 1 and PURPOSE 2 data, the drug showed exceptional efficacy, with =99.9% of participants remaining HIV-negative. The long-acting injection aims to overcome barriers such as adherence challenges, stigma, and low awareness that limit current PrEP use. Yeztugo’s approval offers a promising tool to help reduce new HIV infections across diverse populations. Gilead is also implementing broad access measures, including insurance partnerships, co-pay support for eligible patients, and free access for uninsured individuals through assistance programs.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Human Immunodeficiency Virus Therapeutics Market?

In July 2025, Future Pak, a US-based contract development and manufacturing organization (CDMO), acquired Theratechnologies Inc. for up to $254 million. With this acquisition, Future Pak aims to deepen its position in the HIV therapeutics market by integrating Theratechnologies’ marketed HIV drugs including Trogarzo and Egrifta and leveraging their expertise in commercialization to drive further growth. Theratechnologies, headquartered in Canada, is a biopharmaceutical company known for its HIV focused product portfolio, including its monoclonal antibody Trogarzo (ibalizumab) and HIV-associated lipodystrophy treatment Egrifta (tesamorelin)

Regional Outlook

North America was the largest region in the human immunodeficiency virus therapeutics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Human Immunodeficiency Virus Therapeutics Market?

The human immunodeficiency virus therapeutics market consists of revenues earned by entities by providing services such as telehealth and remote patient monitoring, patient support and case management services, clinical trials and research services, and HIV testing and diagnosis services. The market value includes the value of related goods sold by the service provider or included within the service offering. The human immunodeficiency virus therapeutics market also includes sales of antiretroviral drugs (ARVs), pre-exposure prophylaxis (PrEP), post-exposure prophylaxis (PEP), and immune system boosters. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Human Immunodeficiency Virus Therapeutics Market Report 2026?

The human immunodeficiency virus therapeutics market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the human immunodeficiency virus therapeutics industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Human Immunodeficiency Virus Therapeutics Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$15.73 billion
Revenue Forecast In 2035	$19.4 billion
Growth Rate	CAGR of 5.6% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Drug Type, Distribution Channel, End-user
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	Gilead Sciences Inc., GlaxoSmithKline plc, Merck & Co. Inc., AbbVie Inc., Johnson & Johnson, Bristol Myers Squibb Company, Pfizer Inc., F Hoffmann La Roche Ltd., Sanofi SA, Novartis International AG, Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd., Cipla Limited, Aurobindo Pharma Limited, Hetero Labs Limited, Viatris Inc., Sun Pharmaceutical Industries Ltd., Lupin Limited, Dr Reddy's Laboratories Ltd., Mylan N.V.
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Human Immunodeficiency Virus Therapeutics Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Human Immunodeficiency Virus Therapeutics Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Human Immunodeficiency Virus Therapeutics Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Human Immunodeficiency Virus Therapeutics Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Sustainability, Climate Tech & Circular Economy

4.2. Major Trends

4.2.1 Increasing Adoption Of Combination Antiretroviral Therapies

4.2.2 Rising Shift Toward Long-Acting Injectable Hiv Treatments

4.2.3 Growing Focus On Early And Sustained Viral Suppression

4.2.4 Expansion Of Generic Antiretroviral Drug Availability

4.2.5 Increasing Emphasis On Treatment Adherence And Simplified Regimens

5. Human Immunodeficiency Virus Therapeutics Market Analysis Of End Use Industries

5.1 Hospitals And Clinics

5.2 Specialty Hiv Treatment Centers

5.3 Public Health Clinics

5.4 Community Health Centers

5.5 Infectious Disease Care Facilities

6. Human Immunodeficiency Virus Therapeutics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Human Immunodeficiency Virus Therapeutics Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Human Immunodeficiency Virus Therapeutics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Human Immunodeficiency Virus Therapeutics Market Size, Comparisons And Growth Rate Analysis

7.3. Global Human Immunodeficiency Virus Therapeutics Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Human Immunodeficiency Virus Therapeutics Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Human Immunodeficiency Virus Therapeutics Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Human Immunodeficiency Virus Therapeutics Market Segmentation

9.1. Global Human Immunodeficiency Virus Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Branded Drugs, Generic Drugs

9.2. Global Human Immunodeficiency Virus Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospital Pharmacies, Online Pharmacies, Retail Pharmacies

9.3. Global Human Immunodeficiency Virus Therapeutics Market, Segmentation By End-user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals And Clinics, Specialty Centers

9.4. Global Human Immunodeficiency Virus Therapeutics Market, Sub-Segmentation Of Branded Drugs, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Biktarvy, Triumeq, Genvoya, Juluca, Dovato, Isentress, Prezista

9.5. Global Human Immunodeficiency Virus Therapeutics Market, Sub-Segmentation Of Generic Drugs, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Tenofovir Disoproxil Fumarate (TDF), Lamivudine, Efavirenz, Zidovudine, Nevirapine, Abacavir, Ritonavir

10. Human Immunodeficiency Virus Therapeutics Market Regional And Country Analysis

10.1. Global Human Immunodeficiency Virus Therapeutics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Human Immunodeficiency Virus Therapeutics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Human Immunodeficiency Virus Therapeutics Market

11.1. Asia-Pacific Human Immunodeficiency Virus Therapeutics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Human Immunodeficiency Virus Therapeutics Market, Segmentation By Drug Type, Segmentation By Distribution Channel, Segmentation By End-user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Human Immunodeficiency Virus Therapeutics Market

12.1. China Human Immunodeficiency Virus Therapeutics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Human Immunodeficiency Virus Therapeutics Market, Segmentation By Drug Type, Segmentation By Distribution Channel, Segmentation By End-user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Human Immunodeficiency Virus Therapeutics Market

13.1. India Human Immunodeficiency Virus Therapeutics Market, Segmentation By Drug Type, Segmentation By Distribution Channel, Segmentation By End-user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Human Immunodeficiency Virus Therapeutics Market

14.1. Japan Human Immunodeficiency Virus Therapeutics Market Overview

14.2. Japan Human Immunodeficiency Virus Therapeutics Market, Segmentation By Drug Type, Segmentation By Distribution Channel, Segmentation By End-user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Human Immunodeficiency Virus Therapeutics Market

15.1. Australia Human Immunodeficiency Virus Therapeutics Market, Segmentation By Drug Type, Segmentation By Distribution Channel, Segmentation By End-user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Human Immunodeficiency Virus Therapeutics Market

16.1. Indonesia Human Immunodeficiency Virus Therapeutics Market, Segmentation By Drug Type, Segmentation By Distribution Channel, Segmentation By End-user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Human Immunodeficiency Virus Therapeutics Market

17.1. South Korea Human Immunodeficiency Virus Therapeutics Market Overview

17.2. South Korea Human Immunodeficiency Virus Therapeutics Market, Segmentation By Drug Type, Segmentation By Distribution Channel, Segmentation By End-user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Human Immunodeficiency Virus Therapeutics Market

18.1. Taiwan Human Immunodeficiency Virus Therapeutics Market Overview

18.2. Taiwan Human Immunodeficiency Virus Therapeutics Market, Segmentation By Drug Type, Segmentation By Distribution Channel, Segmentation By End-user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Human Immunodeficiency Virus Therapeutics Market

19.1. South East Asia Human Immunodeficiency Virus Therapeutics Market Overview

19.2. South East Asia Human Immunodeficiency Virus Therapeutics Market, Segmentation By Drug Type, Segmentation By Distribution Channel, Segmentation By End-user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Human Immunodeficiency Virus Therapeutics Market

20.1. Western Europe Human Immunodeficiency Virus Therapeutics Market Overview

20.2. Western Europe Human Immunodeficiency Virus Therapeutics Market, Segmentation By Drug Type, Segmentation By Distribution Channel, Segmentation By End-user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Human Immunodeficiency Virus Therapeutics Market

21.1. UK Human Immunodeficiency Virus Therapeutics Market, Segmentation By Drug Type, Segmentation By Distribution Channel, Segmentation By End-user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Human Immunodeficiency Virus Therapeutics Market

22.1. Germany Human Immunodeficiency Virus Therapeutics Market, Segmentation By Drug Type, Segmentation By Distribution Channel, Segmentation By End-user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Human Immunodeficiency Virus Therapeutics Market

23.1. France Human Immunodeficiency Virus Therapeutics Market, Segmentation By Drug Type, Segmentation By Distribution Channel, Segmentation By End-user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Human Immunodeficiency Virus Therapeutics Market

24.1. Italy Human Immunodeficiency Virus Therapeutics Market, Segmentation By Drug Type, Segmentation By Distribution Channel, Segmentation By End-user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Human Immunodeficiency Virus Therapeutics Market

25.1. Spain Human Immunodeficiency Virus Therapeutics Market, Segmentation By Drug Type, Segmentation By Distribution Channel, Segmentation By End-user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Human Immunodeficiency Virus Therapeutics Market

26.1. Eastern Europe Human Immunodeficiency Virus Therapeutics Market Overview

26.2. Eastern Europe Human Immunodeficiency Virus Therapeutics Market, Segmentation By Drug Type, Segmentation By Distribution Channel, Segmentation By End-user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Human Immunodeficiency Virus Therapeutics Market

27.1. Russia Human Immunodeficiency Virus Therapeutics Market, Segmentation By Drug Type, Segmentation By Distribution Channel, Segmentation By End-user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Human Immunodeficiency Virus Therapeutics Market

28.1. North America Human Immunodeficiency Virus Therapeutics Market Overview

28.2. North America Human Immunodeficiency Virus Therapeutics Market, Segmentation By Drug Type, Segmentation By Distribution Channel, Segmentation By End-user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Human Immunodeficiency Virus Therapeutics Market

29.1. USA Human Immunodeficiency Virus Therapeutics Market Overview

29.2. USA Human Immunodeficiency Virus Therapeutics Market, Segmentation By Drug Type, Segmentation By Distribution Channel, Segmentation By End-user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Human Immunodeficiency Virus Therapeutics Market

30.1. Canada Human Immunodeficiency Virus Therapeutics Market Overview

30.2. Canada Human Immunodeficiency Virus Therapeutics Market, Segmentation By Drug Type, Segmentation By Distribution Channel, Segmentation By End-user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Human Immunodeficiency Virus Therapeutics Market

31.1. South America Human Immunodeficiency Virus Therapeutics Market Overview

31.2. South America Human Immunodeficiency Virus Therapeutics Market, Segmentation By Drug Type, Segmentation By Distribution Channel, Segmentation By End-user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Human Immunodeficiency Virus Therapeutics Market

32.1. Brazil Human Immunodeficiency Virus Therapeutics Market, Segmentation By Drug Type, Segmentation By Distribution Channel, Segmentation By End-user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Human Immunodeficiency Virus Therapeutics Market

33.1. Middle East Human Immunodeficiency Virus Therapeutics Market Overview

33.2. Middle East Human Immunodeficiency Virus Therapeutics Market, Segmentation By Drug Type, Segmentation By Distribution Channel, Segmentation By End-user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Human Immunodeficiency Virus Therapeutics Market

34.1. Africa Human Immunodeficiency Virus Therapeutics Market Overview

34.2. Africa Human Immunodeficiency Virus Therapeutics Market, Segmentation By Drug Type, Segmentation By Distribution Channel, Segmentation By End-user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Human Immunodeficiency Virus Therapeutics Market Regulatory and Investment Landscape

36. Human Immunodeficiency Virus Therapeutics Market Competitive Landscape And Company Profiles

36.1. Human Immunodeficiency Virus Therapeutics Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Human Immunodeficiency Virus Therapeutics Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Human Immunodeficiency Virus Therapeutics Market Company Profiles

36.3.1. Gilead Sciences Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.4. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis

37. Human Immunodeficiency Virus Therapeutics Market Other Major And Innovative Companies

Bristol Myers Squibb Company, Pfizer Inc., F Hoffmann La Roche Ltd., Sanofi SA, Novartis International AG, Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd., Cipla Limited, Aurobindo Pharma Limited, Hetero Labs Limited, Viatris Inc., Sun Pharmaceutical Industries Ltd., Lupin Limited, Dr Reddy's Laboratories Ltd., Mylan N.V.

38. Global Human Immunodeficiency Virus Therapeutics Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Human Immunodeficiency Virus Therapeutics Market

40. Human Immunodeficiency Virus Therapeutics Market High Potential Countries, Segments and Strategies

40.1 Human Immunodeficiency Virus Therapeutics Market In 2030 - Countries Offering Most New Opportunities

40.2 Human Immunodeficiency Virus Therapeutics Market In 2030 - Segments Offering Most New Opportunities

40.3 Human Immunodeficiency Virus Therapeutics Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Human Immunodeficiency Virus Therapeutics Market, Overview Of Key Products - Product Examples

Table 2: Global Human Immunodeficiency Virus Therapeutics Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Human Immunodeficiency Virus Therapeutics Market, Supply Chain Analysis

Table 4: Global Human Immunodeficiency Virus Therapeutics Market, Major Raw Material Providers

Table 5: Global Human Immunodeficiency Virus Therapeutics Market, Major Resource Providers

Table 6: Global Human Immunodeficiency Virus Therapeutics Market, Major Manufacturers (Suppliers)

Table 7: Global Human Immunodeficiency Virus Therapeutics Market, Major Distributors And Channel Partners

Table 8: Global Human Immunodeficiency Virus Therapeutics Market, Key Technologies & Future Trends

Table 9: Global Human Immunodeficiency Virus Therapeutics Market, Major Trends

Table 10: Global Human Immunodeficiency Virus Therapeutics Market, Major End Users

Table 11: Global Human Immunodeficiency Virus Therapeutics Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Human Immunodeficiency Virus Therapeutics Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Human Immunodeficiency Virus Therapeutics Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Human Immunodeficiency Virus Therapeutics Market - TAM, US$ Billion, 2025

Table 15: Global Human Immunodeficiency Virus Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Human Immunodeficiency Virus Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Human Immunodeficiency Virus Therapeutics Market, Segmentation By End-user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Human Immunodeficiency Virus Therapeutics Market, Sub-Segmentation Of Branded Drugs, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Human Immunodeficiency Virus Therapeutics Market, Sub-Segmentation Of Generic Drugs, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Human Immunodeficiency Virus Therapeutics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Human Immunodeficiency Virus Therapeutics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Asia-Pacific, Human Immunodeficiency Virus Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Asia-Pacific, Human Immunodeficiency Virus Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Asia-Pacific, Human Immunodeficiency Virus Therapeutics Market, Segmentation By End-user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: China, Human Immunodeficiency Virus Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: China, Human Immunodeficiency Virus Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: China, Human Immunodeficiency Virus Therapeutics Market, Segmentation By End-user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: India, Human Immunodeficiency Virus Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: India, Human Immunodeficiency Virus Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: India, Human Immunodeficiency Virus Therapeutics Market, Segmentation By End-user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: Japan, Human Immunodeficiency Virus Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: Japan, Human Immunodeficiency Virus Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: Japan, Human Immunodeficiency Virus Therapeutics Market, Segmentation By End-user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: Australia, Human Immunodeficiency Virus Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Australia, Human Immunodeficiency Virus Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Australia, Human Immunodeficiency Virus Therapeutics Market, Segmentation By End-user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Indonesia, Human Immunodeficiency Virus Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Indonesia, Human Immunodeficiency Virus Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Indonesia, Human Immunodeficiency Virus Therapeutics Market, Segmentation By End-user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: South Korea, Human Immunodeficiency Virus Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: South Korea, Human Immunodeficiency Virus Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: South Korea, Human Immunodeficiency Virus Therapeutics Market, Segmentation By End-user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: Taiwan, Human Immunodeficiency Virus Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: Taiwan, Human Immunodeficiency Virus Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: Taiwan, Human Immunodeficiency Virus Therapeutics Market, Segmentation By End-user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: South East Asia, Human Immunodeficiency Virus Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: South East Asia, Human Immunodeficiency Virus Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: South East Asia, Human Immunodeficiency Virus Therapeutics Market, Segmentation By End-user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: Western Europe, Human Immunodeficiency Virus Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: Western Europe, Human Immunodeficiency Virus Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: Western Europe, Human Immunodeficiency Virus Therapeutics Market, Segmentation By End-user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: UK, Human Immunodeficiency Virus Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: UK, Human Immunodeficiency Virus Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: UK, Human Immunodeficiency Virus Therapeutics Market, Segmentation By End-user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: Germany, Human Immunodeficiency Virus Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: Germany, Human Immunodeficiency Virus Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: Germany, Human Immunodeficiency Virus Therapeutics Market, Segmentation By End-user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: France, Human Immunodeficiency Virus Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: France, Human Immunodeficiency Virus Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: France, Human Immunodeficiency Virus Therapeutics Market, Segmentation By End-user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: Italy, Human Immunodeficiency Virus Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: Italy, Human Immunodeficiency Virus Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: Italy, Human Immunodeficiency Virus Therapeutics Market, Segmentation By End-user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: Spain, Human Immunodeficiency Virus Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Spain, Human Immunodeficiency Virus Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Spain, Human Immunodeficiency Virus Therapeutics Market, Segmentation By End-user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Eastern Europe, Human Immunodeficiency Virus Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Eastern Europe, Human Immunodeficiency Virus Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Eastern Europe, Human Immunodeficiency Virus Therapeutics Market, Segmentation By End-user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Russia, Human Immunodeficiency Virus Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Russia, Human Immunodeficiency Virus Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Russia, Human Immunodeficiency Virus Therapeutics Market, Segmentation By End-user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: North America, Human Immunodeficiency Virus Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: North America, Human Immunodeficiency Virus Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: North America, Human Immunodeficiency Virus Therapeutics Market, Segmentation By End-user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: USA, Human Immunodeficiency Virus Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: USA, Human Immunodeficiency Virus Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: USA, Human Immunodeficiency Virus Therapeutics Market, Segmentation By End-user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: Canada, Human Immunodeficiency Virus Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: Canada, Human Immunodeficiency Virus Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: Canada, Human Immunodeficiency Virus Therapeutics Market, Segmentation By End-user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: South America, Human Immunodeficiency Virus Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: South America, Human Immunodeficiency Virus Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: South America, Human Immunodeficiency Virus Therapeutics Market, Segmentation By End-user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: Brazil, Human Immunodeficiency Virus Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: Brazil, Human Immunodeficiency Virus Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: Brazil, Human Immunodeficiency Virus Therapeutics Market, Segmentation By End-user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: Middle East, Human Immunodeficiency Virus Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: Middle East, Human Immunodeficiency Virus Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Middle East, Human Immunodeficiency Virus Therapeutics Market, Segmentation By End-user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Africa, Human Immunodeficiency Virus Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Africa, Human Immunodeficiency Virus Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Africa, Human Immunodeficiency Virus Therapeutics Market, Segmentation By End-user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Global Human Immunodeficiency Virus Therapeutics Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 95: Global Human Immunodeficiency Virus Therapeutics Market - Company Scoring Matrix

Table 96: Gilead Sciences Inc. Financial Performance

Table 97: GlaxoSmithKline plc Financial Performance

Table 98: Merck & Co. Inc. Financial Performance

Table 99: AbbVie Inc. Financial Performance

Table 100: Johnson & Johnson Financial Performance

Table 101: Global Human Immunodeficiency Virus Therapeutics Market, Competitive Benchmarking (In USD Billions)

Table 102: Global Human Immunodeficiency Virus Therapeutics Market, Competitive Dashboard

Table 103: Global Human Immunodeficiency Virus Therapeutics Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 104: Global, Human Immunodeficiency Virus Therapeutics Market Size Gain ($ Billion), Segmentation By Drug Type, 2025 – 2030

Table 105: Global, Human Immunodeficiency Virus Therapeutics Market Size Gain ($ Billion), Segmentation By Distribution Channel, 2025 – 2030

Table 106: Global, Human Immunodeficiency Virus Therapeutics Market Size Gain ($ Billion), Segmentation By End-user, 2025 – 2030

List Of Figures

Figure 1: Global Human Immunodeficiency Virus Therapeutics Market, Overview Of Key Products - Product Examples

Figure 2: Global Human Immunodeficiency Virus Therapeutics Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Human Immunodeficiency Virus Therapeutics Market, Supply Chain Analysis

Figure 4: Global Human Immunodeficiency Virus Therapeutics Market, Major Raw Material Providers

Figure 5: Global Human Immunodeficiency Virus Therapeutics Market, Major Resource Providers

Figure 6: Global Human Immunodeficiency Virus Therapeutics Market, Major Manufacturers (Suppliers)

Figure 7: Global Human Immunodeficiency Virus Therapeutics Market, Major Distributors And Channel Partners

Figure 8: Global Human Immunodeficiency Virus Therapeutics Market, Key Technologies & Future Trends

Figure 9: Global Human Immunodeficiency Virus Therapeutics Market, Major Trends

Figure 10: Global Human Immunodeficiency Virus Therapeutics Market, Major End Users

Figure 11: Global Human Immunodeficiency Virus Therapeutics Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Human Immunodeficiency Virus Therapeutics Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Human Immunodeficiency Virus Therapeutics Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Human Immunodeficiency Virus Therapeutics Market - TAM, US$ Billion, 2025

Figure 15: Global Human Immunodeficiency Virus Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Human Immunodeficiency Virus Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Human Immunodeficiency Virus Therapeutics Market, Segmentation By End-user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Human Immunodeficiency Virus Therapeutics Market, Sub-Segmentation Of Branded Drugs, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Human Immunodeficiency Virus Therapeutics Market, Sub-Segmentation Of Generic Drugs, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Human Immunodeficiency Virus Therapeutics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Human Immunodeficiency Virus Therapeutics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Asia-Pacific, Human Immunodeficiency Virus Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Asia-Pacific, Human Immunodeficiency Virus Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Asia-Pacific, Human Immunodeficiency Virus Therapeutics Market, Segmentation By End-user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: China, Human Immunodeficiency Virus Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: China, Human Immunodeficiency Virus Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: China, Human Immunodeficiency Virus Therapeutics Market, Segmentation By End-user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: India, Human Immunodeficiency Virus Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: India, Human Immunodeficiency Virus Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: India, Human Immunodeficiency Virus Therapeutics Market, Segmentation By End-user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: Japan, Human Immunodeficiency Virus Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: Japan, Human Immunodeficiency Virus Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: Japan, Human Immunodeficiency Virus Therapeutics Market, Segmentation By End-user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: Australia, Human Immunodeficiency Virus Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Australia, Human Immunodeficiency Virus Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Australia, Human Immunodeficiency Virus Therapeutics Market, Segmentation By End-user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Indonesia, Human Immunodeficiency Virus Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Indonesia, Human Immunodeficiency Virus Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Indonesia, Human Immunodeficiency Virus Therapeutics Market, Segmentation By End-user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: South Korea, Human Immunodeficiency Virus Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: South Korea, Human Immunodeficiency Virus Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: South Korea, Human Immunodeficiency Virus Therapeutics Market, Segmentation By End-user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: Taiwan, Human Immunodeficiency Virus Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: Taiwan, Human Immunodeficiency Virus Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: Taiwan, Human Immunodeficiency Virus Therapeutics Market, Segmentation By End-user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: South East Asia, Human Immunodeficiency Virus Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: South East Asia, Human Immunodeficiency Virus Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: South East Asia, Human Immunodeficiency Virus Therapeutics Market, Segmentation By End-user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: Western Europe, Human Immunodeficiency Virus Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: Western Europe, Human Immunodeficiency Virus Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: Western Europe, Human Immunodeficiency Virus Therapeutics Market, Segmentation By End-user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: UK, Human Immunodeficiency Virus Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: UK, Human Immunodeficiency Virus Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: UK, Human Immunodeficiency Virus Therapeutics Market, Segmentation By End-user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: Germany, Human Immunodeficiency Virus Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: Germany, Human Immunodeficiency Virus Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: Germany, Human Immunodeficiency Virus Therapeutics Market, Segmentation By End-user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: France, Human Immunodeficiency Virus Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: France, Human Immunodeficiency Virus Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: France, Human Immunodeficiency Virus Therapeutics Market, Segmentation By End-user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: Italy, Human Immunodeficiency Virus Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: Italy, Human Immunodeficiency Virus Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: Italy, Human Immunodeficiency Virus Therapeutics Market, Segmentation By End-user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: Spain, Human Immunodeficiency Virus Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Spain, Human Immunodeficiency Virus Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Spain, Human Immunodeficiency Virus Therapeutics Market, Segmentation By End-user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Eastern Europe, Human Immunodeficiency Virus Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Eastern Europe, Human Immunodeficiency Virus Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Eastern Europe, Human Immunodeficiency Virus Therapeutics Market, Segmentation By End-user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Russia, Human Immunodeficiency Virus Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Russia, Human Immunodeficiency Virus Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Russia, Human Immunodeficiency Virus Therapeutics Market, Segmentation By End-user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: North America, Human Immunodeficiency Virus Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: North America, Human Immunodeficiency Virus Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: North America, Human Immunodeficiency Virus Therapeutics Market, Segmentation By End-user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: USA, Human Immunodeficiency Virus Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: USA, Human Immunodeficiency Virus Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: USA, Human Immunodeficiency Virus Therapeutics Market, Segmentation By End-user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: Canada, Human Immunodeficiency Virus Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: Canada, Human Immunodeficiency Virus Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: Canada, Human Immunodeficiency Virus Therapeutics Market, Segmentation By End-user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: South America, Human Immunodeficiency Virus Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: South America, Human Immunodeficiency Virus Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: South America, Human Immunodeficiency Virus Therapeutics Market, Segmentation By End-user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: Brazil, Human Immunodeficiency Virus Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: Brazil, Human Immunodeficiency Virus Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: Brazil, Human Immunodeficiency Virus Therapeutics Market, Segmentation By End-user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: Middle East, Human Immunodeficiency Virus Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: Middle East, Human Immunodeficiency Virus Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Middle East, Human Immunodeficiency Virus Therapeutics Market, Segmentation By End-user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Africa, Human Immunodeficiency Virus Therapeutics Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Africa, Human Immunodeficiency Virus Therapeutics Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Africa, Human Immunodeficiency Virus Therapeutics Market, Segmentation By End-user, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Global Human Immunodeficiency Virus Therapeutics Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 95: Global Human Immunodeficiency Virus Therapeutics Market - Company Scoring Matrix

Figure 96: Gilead Sciences Inc. Financial Performance

Figure 97: GlaxoSmithKline plc Financial Performance

Figure 98: Merck & Co. Inc. Financial Performance

Figure 99: AbbVie Inc. Financial Performance

Figure 100: Johnson & Johnson Financial Performance

Figure 101: Global Human Immunodeficiency Virus Therapeutics Market, Competitive Benchmarking (In USD Billions)

Figure 102: Global Human Immunodeficiency Virus Therapeutics Market, Competitive Dashboard

Figure 103: Global Human Immunodeficiency Virus Therapeutics Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 104: Global, Human Immunodeficiency Virus Therapeutics Market Size Gain ($ Billion), Segmentation By Drug Type, 2025 – 2030

Figure 105: Global, Human Immunodeficiency Virus Therapeutics Market Size Gain ($ Billion), Segmentation By Distribution Channel, 2025 – 2030

Figure 106: Global, Human Immunodeficiency Virus Therapeutics Market Size Gain ($ Billion), Segmentation By End-user, 2025 – 2030

Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.4% Projected for Catastrophic Antiphospholipid Syndrome Market From 2025 to 2029

Latest Market Developments in Clinical Risk Grouping Solution Industry: Forecast 2025–2029

2025–2029 Clinical Trial Investigative Site Network Market Outlook: Regional Trends and Growth Forecast

Future Demand and Leading Companies Shaping the Common Cold Market to 2029

Acne Drugs Market Report 2026 - Global Outlook – By Type (Inflammatory Acne Drugs, Non-Inflammatory Acne Drugs), By Therapeutic Class (Retinoids, Antibiotics, Salicylic Aci, Benzoyl Peroxide, Other Therapeutics), By End ...

Antiviral Combination Therapy Market Report 2026 - Global Outlook – By Type (Branded, Generic), By Drug Combination (Nucleotide Reverse Transcriptase Inhibitors/Non-Nucleotide Reverse Transcriptase Inhibitors, Integrase ...

Infectious Disease Therapeutics Market Report 2026 - Global Outlook – By Type (Drugs, Vaccines), By Disease (Tuberculosis, HIV/AIDS, Influenza, Hepatitis, Other Diseases), By End-User (Hospitals And Clinics, Retail Pharm...

Human Immunodeficiency Virus (HIV) Diagnosis Market Report 2026 - Global Outlook – By Product (Consumables, Instruments, Software, Services), By Mode (Self-Test, Lab-Based), By End User (Diagnostic Laboratories, Hospital...

Antivirals Market Report 2026 - Global Outlook – By Type (Branded, Generic), By Drug Class (DNA Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, Neuraminidase Inhibitors, Other Drug classes),...

Oncolytic Virus Therapy Market Report 2026 - Global Outlook – By Therapy Type (Herpes Simplex Virus (HSV)-Based Oncolytic Virus Therapy, Adenovirus-Based Oncolytic Virus Therapy, Reovirus, Poxviruses, Newcastle Disease V...

Hepatitis Therapeutics Market Report 2026 - Global Outlook – By Disease Type (Hepatitis A, Hepatitis B, Hepatitis C, Other Disease Types), By Drug Class (Oral Antivirals, Immune Modulators), By Distribution Channel (Hosp...

Frequently Asked Questions

How big is the Human Immunodeficiency Virus Therapeutics Market?

The Human Immunodeficiency Virus Therapeutics market was valued at $14.9 billion in 2025, increased to $15.73 billion in 2026, and is projected to reach $19.4 billion by 2030.

What is the Human Immunodeficiency Virus Therapeutics market growth?

The global Human Immunodeficiency Virus Therapeutics market is expected to grow at a CAGR of 5.4% from 2026 to 2035 to reach $19.4 billion by 2035.

Who are the key players in Human Immunodeficiency Virus Therapeutics market?

Some Key Players in the Human Immunodeficiency Virus Therapeutics market Include, Gilead Sciences Inc., GlaxoSmithKline plc, Merck & Co. Inc., AbbVie Inc., Johnson & Johnson, Bristol Myers Squibb Company, Pfizer Inc., F Hoffmann La Roche Ltd., Sanofi SA, Novartis International AG, Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd., Cipla Limited, Aurobindo Pharma Limited, Hetero Labs Limited, Viatris Inc., Sun Pharmaceutical Industries Ltd., Lupin Limited, Dr Reddy's Laboratories Ltd., Mylan N.V. .

What is the anticipated growth trend for the Human Immunodeficiency Virus Therapeutics market?

Major trend in this market includes: Long-Acting Injectable Prevention Breakthroughs Transforming HIV Care Accessibility And Adherence Worldwide. For further insights on this market. request a sample here

Which region has the most growth potential in the Human Immunodeficiency Virus Therapeutics market?

North America was the largest region in the human immunodeficiency virus therapeutics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the human immunodeficiency virus therapeutics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.